BrightPath Biotherapeutics Co., Ltd. (4594.T)
JPY 46.0
(-2.17%)
JPY 46.0
(-2.17%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.00 JPY | 0.0% |
| 2022 | - JPY | -100.0% |
| 2021 | 1.00 JPY | 0.0% |
| 2020 | - JPY | 0.0% |
| 2019 | - JPY | 0.0% |
| 2018 | - JPY | -100.0% |
| 2017 | 27.56 Million JPY | -34.84% |
| 2016 | 42.31 Million JPY | 16.75% |
| 2015 | 36.23 Million JPY | -75.6% |
| 2014 | 148.5 Million JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - JPY | -100.0% |
| 2023 Q3 | - JPY | 0.0% |
| 2023 FY | 1.00 JPY | 0.0% |
| 2023 Q4 | 1.00 JPY | 0.0% |
| 2023 Q1 | - JPY | 0.0% |
| 2023 Q2 | - JPY | 0.0% |
| 2022 Q4 | - JPY | 0.0% |
| 2022 Q3 | - JPY | 0.0% |
| 2022 Q2 | - JPY | 0.0% |
| 2022 Q1 | - JPY | -100.0% |
| 2022 FY | - JPY | -100.0% |
| 2021 Q1 | - JPY | 0.0% |
| 2021 Q2 | - JPY | 0.0% |
| 2021 Q3 | 299.9 Million JPY | 0.0% |
| 2021 FY | 1.00 JPY | 0.0% |
| 2021 Q4 | 1.00 JPY | -100.0% |
| 2020 Q2 | - JPY | 0.0% |
| 2020 Q3 | - JPY | 0.0% |
| 2020 Q4 | - JPY | 0.0% |
| 2020 FY | - JPY | 0.0% |
| 2020 Q1 | - JPY | 0.0% |
| 2019 Q3 | - JPY | 0.0% |
| 2019 FY | - JPY | 0.0% |
| 2019 Q1 | - JPY | 0.0% |
| 2019 Q4 | - JPY | 0.0% |
| 2019 Q2 | - JPY | 0.0% |
| 2018 Q2 | 2.4 Million JPY | -65.57% |
| 2018 Q1 | 6.97 Million JPY | -74.71% |
| 2018 Q3 | 191.46 Million JPY | 7877.5% |
| 2018 Q4 | - JPY | -100.0% |
| 2018 FY | - JPY | -100.0% |
| 2017 Q4 | 27.56 Million JPY | -2.63% |
| 2017 FY | 27.56 Million JPY | -34.84% |
| 2017 Q1 | 50.09 Million JPY | 18.41% |
| 2017 Q2 | 27.25 Million JPY | -45.6% |
| 2017 Q3 | 28.31 Million JPY | 3.89% |
| 2016 Q2 | 38.07 Million JPY | 7.67% |
| 2016 Q1 | 35.35 Million JPY | -2.43% |
| 2016 FY | 42.31 Million JPY | 16.75% |
| 2016 Q4 | 42.31 Million JPY | 2.24% |
| 2016 Q3 | 41.38 Million JPY | 8.7% |
| 2015 Q4 | 36.23 Million JPY | -71.27% |
| 2015 Q3 | 126.11 Million JPY | 4.51% |
| 2015 Q2 | 120.67 Million JPY | 0.0% |
| 2015 FY | 36.23 Million JPY | -75.6% |
| 2014 FY | 148.5 Million JPY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 683.01 Million JPY | 100.0% |
| PRISM BioLab Co.,LTD | 17.92 Million JPY | 100.0% |
| GNI Group Ltd. | 2.33 Billion JPY | 100.0% |
| Linical Co., Ltd. | - JPY | -Infinity% |
| Trans Genic Inc. | 2.22 Billion JPY | 100.0% |
| MEDINET Co., Ltd. | 67.48 Million JPY | 100.0% |
| Soiken Holdings Inc. | 1.12 Billion JPY | 100.0% |
| Cytori Cell Research Institute, Inc. | 103.53 Million JPY | 100.0% |
| AnGes, Inc. | 1.61 Billion JPY | 100.0% |
| OncoTherapy Science, Inc. | 73.99 Million JPY | 100.0% |
| Nxera Pharma Co., Ltd. | 2.9 Billion JPY | 100.0% |
| Immuno-Biological Laboratories Co., Ltd. | 321.91 Million JPY | 100.0% |
| NanoCarrier Co., Ltd. | 184 Thousand JPY | 99.999% |
| Carna Biosciences, Inc. | 140.14 Million JPY | 100.0% |
| CanBas Co., Ltd. | 728 Thousand JPY | 100.0% |
| D. Western Therapeutics Institute, Inc. | 87.86 Million JPY | 100.0% |
| RaQualia Pharma Inc. | 147.93 Million JPY | 100.0% |
| Chiome Bioscience Inc. | 64.1 Million JPY | 100.0% |
| Kidswell Bio Corporation | 875.65 Million JPY | 100.0% |
| PeptiDream Inc. | 2.4 Billion JPY | 100.0% |
| Oncolys BioPharma Inc. | 5.34 Million JPY | 100.0% |
| Ribomic Inc. | 2.27 Million JPY | 100.0% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | - JPY | -Infinity% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 36 Million JPY | 100.0% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | 29 Million JPY | 100.0% |
| CellSource Co., Ltd. | 305.92 Million JPY | 100.0% |
| FunPep Company Limited | 25.54 Million JPY | 100.0% |
| Kringle Pharma, Inc. | 364.05 Million JPY | 100.0% |
| Stella Pharma Corporation | 1.11 Billion JPY | 100.0% |
| TMS Co., Ltd. | 50.02 Million JPY | 100.0% |
| Noile-Immune Biotech Inc. | 20.9 Million JPY | 100.0% |
| Cuorips Inc. | 1.04 Million JPY | 100.0% |
| K Pharma,Inc. | 10.79 Million JPY | 100.0% |
| Takara Bio Inc. | 11.85 Billion JPY | 100.0% |
| ReproCELL Incorporated | 248.14 Million JPY | 100.0% |
| PhoenixBio Co., Ltd. | 450.58 Million JPY | 100.0% |
| StemCell Institute Inc. | 42.26 Million JPY | 100.0% |
| Japan Tissue Engineering Co., Ltd. | 228.56 Million JPY | 100.0% |
| CellSeed Inc. | 46.19 Million JPY | 100.0% |